APA

Mukherjee R., Moreno-Fernandez M. E., Giles D. A., Cappelletti M., Stankiewicz T. E., Chan C. C. & Divanovic S. (2018). Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. : Hepatology communications.

Chicago

Mukherjee Rajib, Moreno-Fernandez Maria E, Giles Daniel A, Cappelletti Monica, Stankiewicz Traci E, Chan Calvin C and Divanovic Senad. 2018. Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. : Hepatology communications.

Harvard

Mukherjee R., Moreno-Fernandez M. E., Giles D. A., Cappelletti M., Stankiewicz T. E., Chan C. C. and Divanovic S. (2018). Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. : Hepatology communications.

MLA

Mukherjee Rajib, Moreno-Fernandez Maria E, Giles Daniel A, Cappelletti Monica, Stankiewicz Traci E, Chan Calvin C and Divanovic Senad. Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. : Hepatology communications. 2018.